Equities

Japan Tissue Engineering Co Ltd

7774:TYO

Japan Tissue Engineering Co Ltd

Actions
Health CareMedical Equipment and Services
  • Price (JPY)495.00
  • Today's Change1.00 / 0.20%
  • Shares traded13.10k
  • 1 Year change-3.51%
  • Beta1.2314
Data delayed at least 20 minutes, as of Nov 15 2024 06:30 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in JPYIncome statement in JPYView more

Year on year Japan Tissue Engineering Co Ltd grew revenues 23.70% from 2.03bn to 2.51bn while net income improved from a loss of 729.32m to a gain of 143.17m.
Gross margin63.29%
Net profit margin-2.90%
Operating margin-2.14%
Return on assets-1.06%
Return on equity-1.20%
Return on investment-1.19%
More ▼

Cash flow in JPYView more

In 2024, Japan Tissue Engineering Co Ltd did not generate a significant amount of cash. However, the company earned 274.14m from its operations for a Cash Flow Margin of 10.90%. In addition the company used 242.23m on investing activities and also paid 134.00k in financing cash flows.
Cash flow per share1.85
Price/Cash flow per share266.84
Book value per share144.18
Tangible book value per share141.88
More ▼

Balance sheet in JPYView more

Japan Tissue Engineering Co Ltd has little financial risk as the capital structure does not rely on leverage.
Current ratio8.29
Quick ratio7.97
Total debt/total equity--
Total debt/total capital--
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.